This is a strong bullish signal from a sophisticated 10% owner buying on the open market. The purchase at $21.00/share, combined with $18.7M in total insider buying over the past 30 days, suggests insiders see material upside. Traders should monitor for upcoming catalysts (e.g., pipeline updates, partnership news) that may have prompted this accumulation.
Price Chart
Executive Summary
Goldman Sachs Group Inc., a 10%+ owner of Attovia Therapeutics, purchased 85,000 shares for $1.78M on the open market at $21.00/share on August 5, 2026. This is a large, concentrated insider buy from a sophisticated institutional holder, representing approximately 0.22% of the company's $823M market cap, signaling strong conviction in the company's prospects.
Key Financial Metrics
Key Facts
- Goldman Sachs Group Inc. (10%+ owner) purchased 85,000 shares of ATTO at $21.00/share
- Total purchase value: $1.78 million
- Purchase date: August 5, 2026
- Market cap: $823 million
- Recent insider activity (30d): 3 buys totaling $18.7M, indicating sustained insider accumulation
Financial Impact
Insider purchase of $1.78M represents ~0.22% of market cap, a significant conviction buy from a major institutional holder
Risk Factors
- Biotech stocks are binary and high-risk; insider buys do not guarantee positive outcomes
- Goldman Sachs may have other strategic motives beyond pure investment conviction
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| INSIDER-BUY Data (Synthetic) | 0000886982-26-000495 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 18d ago | 3/A | $16.21 | awaiting T+20 | — | $14.19 (−12.46%) |
Oct 8, 2026 18d ago | 3/A | $16.21 | awaiting T+20 | — | $14.19 (−12.46%) |
Sep 28, 2026 28d ago | Press Release | $18.16 | awaiting T+20 | — | $14.19 (−21.86%) |
Sep 2, 2026 7w ago | Press Release | $24.20 $17.14 | ▼ −29.17% | ▼ −28.06% | $14.19 (−41.36%) |
Aug 28, 2026 8w ago | 144 / CLUSTER | $21.40 $18.16 | ▼ −15.14% | ▼ −14.95% | $14.19 (−33.69%) |
Aug 13, 2026 10w ago | Insider Buy | $19.86 $24.52 | ▲ +23.46% | ▲ +25.46% | $14.19 (−28.55%) |
Aug 13, 2026 10w ago | Insider Cluster | $19.86 $24.52 | ▲ +23.46% | ▲ +25.46% | $14.19 (−28.55%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.65 $22.86 | ▲ +22.57% | ▲ +23.63% | $14.19 (−23.91%) |
Aug 7, 2026 11w ago | Insider Cluster | $19.84 $23.66 | ▲ +19.25% | ▲ +20.17% | $14.19 (−28.48%) |
Aug 7, 2026 11w ago | Insider Cluster | $20.17 $25.55 | ▲ +26.67% | ▲ +27.07% | $14.19 (−29.65%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers